Johnson & Johnson
JNJ
$160.26
Share price
-0.15%
Change (1 day)
-3.28%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Johnson & Johnson (JNJ) - P/B ratio
P/B ratio as of September 2023 : 5.45
According to Johnson & Johnson's latest financial reports the company has a price-to-book ratio of 5.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Johnson & Johnson - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 6.01 | -1.16% |
| 2021-12-31 | 6.08 | -7.08% |
| 2020-12-31 | 6.55 | 1.4% |
| 2019-12-31 | 6.46 | 12.3% |
| 2018-12-31 | 5.75 | -7.84% |
| 2017-12-31 | 6.24 | 40.18% |
| 2016-12-31 | 4.45 | 11.42% |
| 2015-12-31 | 3.99 | -4.26% |
| 2014-12-31 | 4.17 | 19.6% |
| 2013-12-31 | 3.49 | 16.11% |
| 2012-12-31 | 3.00 | -4.24% |
| 2011-12-31 | 3.14 | 4.51% |
| 2010-12-31 | 3.00 | -14.54% |
| 2009-12-31 | 3.51 | -10.04% |
| 2008-12-31 | 3.90 | -10.71% |
| 2007-12-31 | 4.37 | -9.98% |
| 2006-12-31 | 4.86 | 2.92% |
| 2005-12-31 | 4.72 | -20.3% |
| 2004-12-31 | 5.92 | 3.79% |
| 2003-12-31 | 5.71 | -18.76% |
| 2002-12-31 | 7.02 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.07 | -25.19% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.84 | -66.22% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.54 | -16.57% | 🇺🇸 USA |
 Medtronic MDT | 2.06 | -62.18% | 🇮🇪 Ireland |
 Eli Lilly LLY | 47.0 | 763.56% | 🇺🇸 USA |
 Sanofi SNY | 1.76 | -67.76% | 🇫🇷 France |
 Gilead Sciences GILD | 4.42 | -18.83% | 🇺🇸 USA |
 Stryker Corporation SYK | 6.29 | 15.45% | 🇺🇸 USA |
 Merck MRK | 5.73 | 5.15% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.07 | -6.80% | 🇬🇧 UK |